Neratinib kills B-RAF V600E melanoma via ROS-dependent autophagosome formation and death receptor signaling.

Neratinib kills B-RAF V600E melanoma via ROS-dependent autophagosome formation and death receptor signaling. Pigment Cell Melanoma Res. 2022 01; 35(1):66-77.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Autophagosomes
Cell Line, Tumor
Dose-Response Relationship, Drug
Drug Synergism
Histone Deacetylase Inhibitors
Humans
Melanoma
Mutation
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Quinolines
Reactive Oxygen Species
Receptors, Death Domain
Signal Transduction
Skin Neoplasms

authors with profiles

JOHN KIRKWOOD